Neoolife is pioneering and leading the field of tissue-engineered Biomimetic Heart Valves (BMHV) with polymeric scaffolds enabling endogenous in-situ tissue regeneration.
Neoolife will replace mechanical and animal-derived tissue valves with tissue-engineered Biomimetic Heart Valves designed to have an extended duration without the need for blood-thinning drugs.
Neoolife tissue-engineered Biomimetic Heart Valves provide a technological solution to the clinicians’ demands of enlarging the pool of patients that can benefit from Transcatheter Heart Valve Therapy.
Intensive animal farming to support the medical industry is a polluting reservoir for pathogens causing lethal diseases in humans. Our animal-free technology eliminates transmission risks while maintaining supplies security.¹
Neoolife’ s unique polymeric scaffolds mimic the natural structure, shape, size, and function of human heart valves. This biomimicry promotes endogenous tissue regeneration to achieve native living tissue remodeling.
Immediately after implantation, Neoolife valves have a function equivalent to native heart valves. Moreover, the endogenous living tissue that populates the scaffold is non-thrombogenic, resistant to calcification, and durable.
Neoolife products rely upon a more efficient, scalable, and less costly manufacturing process. Our products are based on consistent and reproducible quality, including robotic technology for a high level of precision and customization.
NAI Senior Members are active faculty, scientists and administrators from NAI member insti...
The Society For Biomaterials hosted its 2022 Annual Meeting at the Baltimore Marriott Wate...
Pittsburgh – Professor Antonio D’Amore, Chief Technology Officer of Neoolife,...